|
Company:
|
PACIRA BIOSCIENCES, INC. (PCRX)
|
|
Form Type:
|
4
|
|
Filing Date:
|
8/16/2019
|
|
CIK:
|
0001396814
|
|
Address:
|
5 SYLVAN WAY
SUITE 300
|
|
City, State, Zip:
|
PARSIPPANY, New Jersey 07054
|
|
Telephone:
|
973-254-3560
|
|
Fiscal Year:
|
12/31
|
|
|
|
|
|
Last Trade
|
Last Trade:
$68.59
|
Change:
-1.21 (-1.73%)
|
Trade Time:
04:00 PM EST
|
Market Cap:
$2.98B
|
|
|
|
|
|
|
Description of Business
|
|
Pacira BioSciences, Inc., a Delaware corporation, changed its name from Pacira
Pharmaceuticals, Inc. upon completing its acquisition of MyoScience, a
privately-held medical technology company, in April 2019 (referred to herein as
the "MyoScience Acquisition") in order to better reflect a broadening portfolio
of innovative non-opioid pain management and regenerative health solutions.
Pacira BioSciences, Inc. is the holding company for our California operating
subsidiary named Pacira Pharmaceuticals, Inc., or Pacira California. In March
2007, we acquired Pacira California from SkyePharma Holdings, Inc. (now a
subsidiary of Vectura Group plc), or Skyepharma (referred to herein as the
"Skyepharma Acquisition"). Pacira California retained the name Pacira
Pharmaceuticals, Inc. upon the completion of the MyoScience Acquisition. Unless
the context requires otherwise, references to "Pacira," "we," the "Company,"
"us" and "our" in this Annual Report refers to Pacira BioSciences, Inc.
|
|
|
|